✦ LIBER ✦

P108 VISILIZUMAB THERAPY IN SUBJECTS WITH MODERATE-TO-SEVERE, REFRACTORY CROHN'S DISEASE

✍ Scribed by D.W. Hommes; S.R. Targan; A. Dignass; D.C. Baumgart; L. Mayer; L. Zhang; K. Wilson; T. Pearce

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P386 Pharmacokinetics of laquinimod in p

✍ D'Haens, G.; Sandborn, W.J.; Rutgeerts, P.; Colombel, J.F.; Mimrod, D.; Spiegels 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

P411 Pharmacokinetics of adalimumab in p

✍ Eckert, D.; Mensing, S.; Sharma, S.; Thakkar, R.; Robinson, A.; Hyams, J.; Rosh, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 57 KB

P380 Predictors of clinical response to

✍ Koo, J.S.; Keum, B.; Lee, B.J.; Jeen, Y.J.; Choi, J.H. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P.06.12 NUTRITIONAL EFFECTS OF ANTI-TNF-

✍ S. Mazzuoli; I. Addante; S. Fragnan; N. Regano; M. Rizzi; G. Leogrande; A. Di Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P090 - Autologous mesenchymal stem cell

✍ M. Duijvestein; M.H. Verwey; H.H. Fidder; G.R. van den Brink; H. Roelofs; J. Zwa 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 58 KB

P148 - Adalimumab maintains long-term re

✍ R. Panaccione; J.F. Colombel; W.J. Sandborn; P. Rutgeerts; G. D'Haens; K.G. Loma 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 61 KB